Glucose 5% Sodium Chloride 0.45% New Zealand - English - Medsafe (Medicines Safety Authority)

glucose 5% sodium chloride 0.45%

baxter healthcare ltd - glucose 5%; sodium chloride 0.45% - solution for infusion - active: glucose 5% sodium chloride 0.45% excipient: water for injection - glucose and sodium chloride infusion solution is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of medication delivery where intravenous delivery is appropriate and the medicine is compatible with this solution.

Glucose 2.5% Sodium Chloride 0.45% New Zealand - English - Medsafe (Medicines Safety Authority)

glucose 2.5% sodium chloride 0.45%

baxter healthcare ltd - glucose 2.5%; sodium chloride 0.45% - solution for infusion - active: glucose 2.5% sodium chloride 0.45% - glucose and sodium chloride infusion solution is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of medication delivery where intravenous delivery is appropriate and the medicine is compatible with this solution.

Glucose 4% Sodium Chloride 0.18% New Zealand - English - Medsafe (Medicines Safety Authority)

glucose 4% sodium chloride 0.18%

baxter healthcare ltd - glucose 4%; sodium chloride 0.18% - solution for infusion - active: glucose 4% sodium chloride 0.18% - glucose and sodium chloride infusion solution is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of medication delivery where intravenous delivery is appropriate and the medicine is compatible with this solution.

Glucose 5% Sodium Chloride 0.9% New Zealand - English - Medsafe (Medicines Safety Authority)

glucose 5% sodium chloride 0.9%

baxter healthcare ltd - glucose 5%; sodium chloride 0.9% - solution for infusion - active: glucose 5% sodium chloride 0.9% - glucose and sodium chloride infusion solution is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of medication delivery where intravenous delivery is appropriate and the medicine is compatible with this solution.

Glucose Intravenous Infusion BP 50% w/v Malta - English - Medicines Authority

glucose intravenous infusion bp 50% w/v

central procurement & supplies unit - glucose - injection - glucose 50 percent weight/volume - blood substitutes and perfusion solutions

Dianeal PD4 Glucose 3.86 % w/v (38.6 mg/ml), Solution for peritoneal dialysis Ireland - English - HPRA (Health Products Regulatory Authority)

dianeal pd4 glucose 3.86 % w/v (38.6 mg/ml), solution for peritoneal dialysis

baxter holding b.v. - glucose anhydrous ; glucose monohydrate; sodium chloride; sodium lactate ; calcium chloride dihydrate; magnesium chloride hexahydrate - solution for peritoneal dialysis - 3.86 percent weight/volume - hypertonic solutions

Glucose 5% Intravenous Infusion BP Malta - English - Medicines Authority

glucose 5% intravenous infusion bp

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - glucose monohydrate - solution for infusion - glucose monohydrate 50 g/l - blood substitutes and perfusion solutions

Glucose Intravenous Infusion BP 50% w/v Malta - English - Medicines Authority

glucose intravenous infusion bp 50% w/v

jv healthcare limited navi buidlings, pantar road, lija, lja 2021, malta - glucose - injection - glucose 50 % (w/v) - blood substitutes and perfusion solutions

SMOFKABIVEN amino acids 5.1% / lipids 3.8% / glucose 12.7% / electrolytes 0.7% emulsion for intravenous infusion bag 2463 mL Australia - English - Department of Health (Therapeutic Goods Administration)

smofkabiven amino acids 5.1% / lipids 3.8% / glucose 12.7% / electrolytes 0.7% emulsion for intravenous infusion bag 2463 ml

fresenius kabi australia pty ltd - medium chain triglycerides, quantity: 60 g/l; fish oil - rich in omega-3 acids, quantity: 30 g/l; olive oil, quantity: 50 g/l; soya oil, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: sodium oleate; dl-alpha-tocopherol; glycerol; egg lecithin; water for injections; sodium hydroxide - parenteral nutrition for adult patients and paediatric patients aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated.

SMOFKABIVEN amino acids 5.1% / lipids 3.8% / glucose 12.7% / electrolytes 0.7% emulsion for intravenous infusion bag 1970 mL Australia - English - Department of Health (Therapeutic Goods Administration)

smofkabiven amino acids 5.1% / lipids 3.8% / glucose 12.7% / electrolytes 0.7% emulsion for intravenous infusion bag 1970 ml

fresenius kabi australia pty ltd - fish oil - rich in omega-3 acids, quantity: 30 g/l; soya oil, quantity: 60 g/l; olive oil, quantity: 50 g/l; medium chain triglycerides, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; sodium oleate; egg lecithin; glycerol; water for injections; dl-alpha-tocopherol - parenteral nutrition for adult patients and paediatric patients aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated.